Amanote Research
Register
Sign In
Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.14657
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
May 17, 2018
Authors
M. T. Wei
M. H. Nguyen
Publisher
Wiley
Related search
Efficacy and Safety of Peginterferon Alfa-2a (40KD) in Children With Chronic Hepatitis B: The PEG-B-ACTIVE Study
Hepatology
Medicine
Hepatology
Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Impact of Pegylated Interferon-Alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study
Hepatitis Monthly
Hepatology
Infectious Diseases
Serum Hepatitis B Virus RNA Levels as a Predictor of HBeAg Seroconversion During Treatment With Peginterferon Alfa-2a
Virology Journal
Virology
Infectious Diseases
Interferon and Lamivudine vs. Interferon for Hepatitis B E Antigen-Positive Hepatitis B Treatment: Meta-Analysis of Randomized Controlled Trials
Liver International
Hepatology
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients With Elevated Hepatitis B Virus DNA Levels
PLoS ONE
Multidisciplinary
Randomised Controlled Trial of Interferon Alfa (Lymphoblastoid Interferon) in Chronic Non-A Non-B Hepatitis.
BMJ
Low Dose Interferon Alfa-2b for Chronic Hepatitis B in Asian Countries.
Gut
Gastroenterology
A Case of Hepatitis B Surface Antigen Positive Chronic Hepatitis With Sarcoidosis.
Acta Hepatologica Japonica
Hepatology
